Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2008, Ysios Capital is a European venture capital firm with offices in San Sebastián and Barcelona, Spain. The firm manages over €400 million in assets and has a portfolio of 12 companies. Ysios Capital is dedicated to advancing the biotech sector, particularly in Spain.
Ysios Capital invests globally in biotech ventures, concentrating on innovative therapeutic drugs across various modalities and therapeutic areas. The firm supports companies at late preclinical and early clinical stages, focusing on both asset-centric companies and product-enabling platform technologies. Their investment strategy emphasizes strong scientific foundations and the potential for clinical efficacy.
Notable portfolio companies include: Adcendo (Denmark): Developing targeted anti-cancer therapies; Anaconda Biomed (Spain): Focused on ischemic stroke solutions; Aura Biosciences (USA): Utilizing nanotechnology for cancer treatment; Neurona Therapeutics (USA): Developing regenerative cell therapies for nervous system repair.
Ysios Capital invests in pre-seed, seed, Series A, Series B, and Series C stages, focusing on biotech companies.
The firm prefers companies developing innovative therapeutic drugs with strong scientific foundations, particularly in late preclinical and early clinical stages.
Ysios Capital has offices in San Sebastián and Barcelona, Spain, allowing them to engage closely with the European biotech ecosystem.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.